Results 101 to 110 of about 7,055,245 (153)

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. [PDF]

PLoS One, 2021
Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress AP.   +29 more
europepmc   +1 more source

Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk

, 2011
Csaba FarsangCardiometabolic Center, Department of Internal Medicine, St Imre Hospital, Budapest, HungaryAbstract: The worldwide burden of cardiovascular disease is growing.
Farsang C
core  

Antihypertensive Effect of a Novel Angiotensin II Receptor Blocker Fluorophenyl Benzimidazole: Contribution of cGMP, Voltage-dependent Calcium Channels, and BK_Ca Channels to Vasorelaxant Mechanisms. [PDF]

Front Pharmacol, 2021
Iqbal H, Verma AK, Yadav P, Alam S, Shafiq M, Mishra D, Khan F, Hanif K, Negi AS, Chanda D.   +9 more
europepmc   +1 more source

Critical review of cancer risk associated with angiotensin receptor blocker therapy

, 2011
Grégoire Wuerzner1,3, Michel Burnier1, Bernard Waeber2,31Service of Nephrology and Hypertension Consultation, Centre Hospitalier Universitaire Vaudois, 2Division of Clinical Pathophysiology, Centre Hospitalier Universitaire Vaudois, 3Clinical ...
Burnier M, Wuerzner G, Waeber B
core  

An Angiotensin II Receptor Blocker Suppresses Glucose-Induced Oxidative Stress in Human Rotator Cuff-Derived Cells. [PDF]

J Orthop Res
Takigami S, Mifune Y, Inui A, Yamaura K, Shinohara I, Kusunose M, Tanaka S, Osawa S, Matsumoto T, Kuroda R.   +9 more
europepmc   +1 more source

Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding. [PDF]

J Hypertens, 2021
Cohen JB, D'Agostino McGowan L, Jensen ET, Rigdon J, South AM.   +4 more
europepmc   +1 more source

Impact of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use on Delirium Incidence in ICU Patients: A Retrospective Study. [PDF]

Health Sci Rep
Li Z, Liu S, Wan Q, Niu Y, Yu Y.
europepmc   +1 more source

Effects of esaxerenone add-on therapy versus angiotensin II receptor blocker dose escalation on albuminuria and blood pressure in hypertensive patients with type 2 diabetes: An exploratory randomized study. [PDF]

J Diabetes Investig
Ohara M, Omachi T, Takehana N, Fujikawa T, Osaka N, Irie S, Terasaki M, Mori Y, Matsui T, Yamagishi SI.   +9 more
europepmc   +1 more source

A Digital Twin of the Angiotensin II Receptor Blocker Losartan: Physiologically Based Modeling of Blood Pressure Regulation. [PDF]

Pharmaceutics
Tensil E, Myshkina M, König M.
europepmc   +1 more source

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention

, 2008
Cesare Cuspidi1,2, Francesca Negri2, Alberto Zanchetti31Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Milan, Italy; 2Policlinico di Monza; 3Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Università ...
Francesca Negri, Alberto Zanchetti, Cesare Cuspidi   +2 more
core